<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6963560/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Regimens based on DAAs currently available for treatment of HCV in CKD.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">col0</th>
   <th colspan="1" rowspan="1" id="0-1-.">col1</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Daclatasvir (60 mg)</td>
   <td rowspan="8" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">CKD stage 1,2,3 </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elbasvir/Grazoprevir (50 mg/100 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glecaprevir/Pibrentasvir (300 mg/120 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ledipasvir/Sofosbuvir (90 mg/400 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sofosbuvir/Velpatasvir (400 mg/100 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Simeprevir (150 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sofosbuvir (400 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sofosbuvir/Velpatasvir/Voxilaprevir (400 mg/100 mg/100 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ritonavir-boosted Paritaprevir/Ombitasvir/DasabuvirÂ±Ribavirin 
    <br/>(PrOD or 3D regimen) (50 mg/75 mg/12.5 mg/250 mg/200 mg) 
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">CKD stage 4,5 </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elbasvir/Grazoprevir (50 mg/100 mg)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glecaprevir/Pibrentasvir (300 mg/120 mg)</td>
  </tr>
 </tbody>
</table>
